<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:SPRO (USA) Also Trade In: Germany

Spero Therapeutics Inc $ 10.74 -0.61 (-5.37%)

Volume:
21,312
Avg Vol (1m):
40,156
Market Cap $:
200.37 Mil
Enterprise Value $:
102.16 Mil
P/E (TTM):
0.00
P/B:
1.69
Warning! GuruFocus has detected 3 Severe warning signs with SPRO. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

7/10
Current Vs Industry Vs History
Cash-To-Debt 21.33
Equity-to-Asset 0.89
Debt-to-Equity 0.04
Debt-to-EBITDA -0.12
N/A
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.71
DISTRESS
GREY
SAFE
Beneish M-Score 0.72
Not Manipulator
Manipulator

Profitability

2/10
Current Vs Industry Vs History
Operating Margin % -338.41
Net Margin % -321.37
ROE % -37.18
ROA % -33.58
ROC (Joel Greenblatt) % -935.27
3-Year EBITDA Growth Rate -9.5
N/A
3-Year EPS without NRI Growth Rate -8.5
N/A

Ratios

Current Vs Industry Vs History
PB Ratio 1.69
PS Ratio 15.28
EV-to-EBIT -2.38
N/A
EV-to-EBITDA -2.4
N/A
EV-to-Revenue 8.4
Current Ratio 13.66
Quick Ratio 13.66

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -34.3
N/A

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 1.74
Price-to-Median-PS-Value 0.35
Earnings Yield (Greenblatt) % -40.52